The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ludgate Stephen, McGowan Anne, Moran Carla, Attanasio Roberto, Žarković Miloš, Nagy Endre Vezekenyi, Negro Roberto, Papini Enrico, Adler Cohen Chagit, Akarsu Ersin, Alevizaki Maria, Ayvaz Göksun, Bednarczuk Tomasz, Beleslin Biljana Nedeljković, Berta Eszter, Bodor Miklos, Borissova Anna Maria, Boyanov Mihail, Buffet Camille, Burlacu Maria-Cristina, Ćirić Jamina, Díez Juan J, Dobnig Harald, Fadeyev Valentin, Field Benjamin C T, Fliers Eric, Führer-Sakel Dagmar, Galofré Juan Carlos, Hakala Tommi, Jiskra Jan, Kopp Peter A, Krebs Michael, Kršek Michal, Kužma Martin, Lazúrová Ivica, Leenhardt Laurence, Luchytskiy Vitaliy, Melo Miguel, Metso Saara, Morgunova Tatyana, Niculescu Dan Alexandru, Perić Božidar, Planck Tereza, Poiana Catalina, Marques Puga Francisca, Robenshtok Eyal, Rosselet Patrick, Ruchala Marek, Riis Kamilla Ryom, Shepelkevich Alla, Tronko Mykola D, Frølich Jacob Stampe, Unuane David, Vardarli Irfan, Visser W Edward, Vryonidou Andromachi, Younes Younes Ramazan, Yurenya Elena, Perros Petros, Hegedüs Laszlo
Аннотация
METHODS: The question "Thyroid hormones may be indicated in biochemically euthyroid patients with treatment resistant depression" was posed to specialists from 28 countries.
RESULTS: 5695 valid responses were received following 17,232 invitations (33.0% response rate; 65% female, 90% endocrinologists). 348 (6.1%) stated that TH may be indicated in biochemically euthyroid patients with TRD. This view was more common in males (p<0.01), respondents who saw ≥100 patients with hypothyroidism per year (p<0.01), respondents who worked in private practice (p=0.05) and respondents who were not members of international specialist associations (p=0.05). Geographical variation existed with respondents in Eastern Europe significantly more likely to use TH in TRD (p<0.01). Linear regression showed a statistically significant reduction in the use of TH for TRD with increasing gross national income (F-statistic=7.35, CI -0.15 - -0.02, p=0.01). TH in TRD was recommended in psychiatry guidelines but not endocrinology guidelines.
CONCLUSION: While there is limited evidence for their use, over 6% of respondents stated that TH may be indicated in TRD. Due to the risk of iatrogenic thyrotoxicosis and increased morbidity the use of TH should be addressed in relevant endocrinology guidelines and consensus should be reached between specialties.